Stockreport

Dermavant Announces Publication of ADORING 1 & ADORING 2 Pivotal Phase 3 Trials of VTAMA® (tapinarof) cream, 1% for Adults and Children 2 Years of Age and Older with Atopic Dermatitis in J...

Roivant Sciences Ltd.  (ROIV) 
PDF — ADORING 1 and ADORING 2 data were included in the sNDA filing for VTAMA cream, 1% in atopic dermatitis, submitted in February 2024 — LONG BEACH, Calif. & BASEL, Swi [Read more]